BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35674464)

  • 1.
    Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
    Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
    Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
    J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.
    Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS
    J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
    Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
    Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z
    J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Vulnerable Atherosclerotic Plaques by
    Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
    Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiofluorinated divalent cystine knot peptide for tumor PET imaging.
    Jiang L; Kimura RH; Ma X; Tu Y; Miao Z; Shen B; Chin FT; Shi H; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Nov; 11(11):3885-92. PubMed ID: 24717098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT Imaging of NSCLC with a α
    Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
    Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
    Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot-phase PET/CT study targeting integrin α
    Nakamoto R; Ferri V; Duan H; Hatami N; Goel M; Rosenberg J; Kimura R; Wardak M; Haywood T; Kellow R; Shen B; Park W; Iagaru A; Gambhir SS
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):184-193. PubMed ID: 34729628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Translation of a
    Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
    J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of
    Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
    J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Small Cyclic Peptide-Based
    Liu H; Hu M; Deng J; Zhao Y; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Mol Pharm; 2022 Jan; 19(1):138-147. PubMed ID: 34910492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
    Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
    J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a
    Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
    Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.